When heartburn hits after a rich dinner, many people reach for Gaviscon without really understanding what those minty tablets are doing inside. The good news is that Gaviscon Dual Action has accumulated a surprising amount of clinical evidence behind it — including a randomized trial where it performed almost identically to a common prescription acid reducer.

Primary Use: Heartburn and Indigestion Relief · Formula: Dual Action · Form: Chewable Tablets · Flavour: Mint · Mechanism: Protective Barrier + Neutralizes Acid

Quick snapshot

1Confirmed facts
  • Dual action for symptom relief from official sites (NHS)
  • 89.7% of patients achieved 24-hour heartburn-free period in clinical trial (PubMed Central)
2What’s unclear
  • Exact onset time varies by individual stomach contents
  • Long-term use data for chronic GERD patients is limited
3Timeline signal
  • Onset typically 30 minutes to 2 hours after taking
  • Most patients experience first relief within first 48 hours
4What’s next
  • Consideration of individual symptom patterns to choose between Gaviscon and PPIs
  • Consultation with healthcare provider for chronic symptoms
Attribute Value
Type Chewable Tablets
Flavour Mint
Target Symptoms Heartburn, Indigestion, Acid Regurgitation
Action Dual: Barrier + Neutralizes Stomach Acid
Minimum Age 12 years and over
Sodium per 4-tablet dose 9.72 mmol
Calcium per 4-tablet dose 7.5 mmol
Aspartame per tablet 5.6 mg
Official Sources Gaviscon.co.uk and Medicines.org.uk

What are Gaviscon Double Action Tablets used for?

Gaviscon Double Action tablets are designed for adults and children aged 12 and over who experience symptoms of gastro-oesophageal reflux, which is the medical term for what most people call heartburn or acid indigestion (The Independent Pharmacy). The tablets work through two mechanisms simultaneously: they form a protective foam barrier on top of stomach contents, and they neutralize excess acid that causes the burning sensation.

Symptoms treated

The specific symptoms the tablets address include acid regurgitation (that sour taste creeping up the throat), persistent heartburn, and general indigestion after meals (NHS). Unlike some treatments that simply reduce acid production throughout the body, Gaviscon works locally in the stomach and oesophagus, targeting only the area where symptoms occur.

How it works

The dual-action mechanism is what distinguishes this formulation. The first action creates a raft-like barrier that sits above the stomach contents, physically preventing acid from splashing back up. The second action neutralizes acid on contact, providing faster symptom relief than products that rely on barrier formation alone (NHS). This combination makes it particularly useful for people who experience symptoms after eating.

The implication: if your heartburn comes on predictably after meals rather than being a constant problem, Gaviscon’s localized action may be more suitable than a systemic acid reducer.

What’s the difference between Gaviscon and Gaviscon Dual Action?

Standard Gaviscon relies on alginate technology to form a protective barrier but does not include an antacid component. Gaviscon Dual Action adds sodium bicarbonate to the formulation, giving it the ability to neutralize acid on contact as well as suppress reflux (The Independent Pharmacy). In practice, this means Dual Action can provide faster symptom relief because it tackles the problem from two angles simultaneously.

Formulation differences

The key active ingredients in Gaviscon Double Action are sodium alginate and sodium bicarbonate. Sodium alginate forms the protective raft, while sodium bicarbonate acts as an antacid to neutralize existing acid. Standard Gaviscon contains sodium alginate as the primary active ingredient without the additional bicarbonate component.

Effectiveness comparison

While both products are effective for mild to moderate symptoms, Dual Action’s added antacid component means it can address symptoms more quickly. For patients with occasional, meal-related heartburn, Dual Action offers the convenience of two mechanisms in one tablet rather than needing separate products (The Independent Pharmacy).

What this means: for people who find standard Gaviscon insufficient, the Dual Action formulation may provide meaningful additional relief without requiring a step up to prescription-strength treatments.

How long does it take for Gaviscon Double Action Tablets to work?

Gaviscon Double Action typically begins working within 30 minutes to 2 hours after taking the tablets, according to patient information guidance. The exact onset time depends on factors such as whether the stomach is empty or contains food, the severity of symptoms, and individual metabolism. For most users, noticeable relief comes relatively quickly because the antacid component works immediately on contact with stomach acid.

Onset time

A 14-day randomized controlled trial compared Gaviscon (given as 10 mL doses four times daily) with omeprazole 20 mg in patients experiencing 2 to 6 days of heartburn episodes weekly (PubMed). The mean time to onset of the first 24-hour heartburn-free period was 2.0 days for Gaviscon and 2.0 days for omeprazole, showing no statistically significant difference between the two (PubMed Central). By day 7, however, the omeprazole group had achieved significantly more heartburn-free days (3.7 days) compared to the Gaviscon group (3.1 days, p = 0.02).

Duration of relief

The relief from each dose typically lasts as long as the protective barrier remains in place, which is generally several hours. The formulation is not designed for 24-hour coverage from a single dose but rather for relief at specific times when symptoms occur, such as after meals and at bedtime (The Independent Pharmacy).

The upshot

Clinical data from the GOOD trial shows Gaviscon patients took an average of 2 days to achieve their first full day without heartburn — identical to omeprazole. By day 7, omeprazole pulls ahead slightly, suggesting Gaviscon may be better suited for short-term, meal-triggered symptoms rather than sustained acid management.

The catch: if you have persistent daily heartburn rather than occasional episodes, Gaviscon’s symptom-by-symptom approach may require more frequent dosing than a once-daily proton pump inhibitor.

Is Gaviscon Double Action better than omeprazole?

This depends entirely on what “better” means for your situation. A randomized controlled trial involving over 240 patients found that 89.7% of Gaviscon patients achieved a first 24-hour heartburn-free period compared to 90.1% of omeprazole patients — a difference so small it has no practical meaning (PubMed Central). However, the two drugs work in completely different ways and suit different patient profiles.

Symptomatic treatment comparison

Gaviscon works locally in the stomach to neutralize acid and suppress reflux, while omeprazole is a proton pump inhibitor (PPI) that reduces acid production at the cellular level. For immediate symptom relief of occasional heartburn, Gaviscon has the advantage of faster action. For long-term management of chronic gastro-oesophageal reflux disease, PPIs like omeprazole offer more sustained acid control (EveryDayMeds).

Study insights

The clinical trial found no significant difference in pain intensity reduction between the two treatments by day 7 or day 14. However, overall quality of pain relief by day 7 showed a slight advantage for omeprazole that reached statistical significance (p = 0.049). Adverse events were comparable: 12.6% of Gaviscon patients experienced at least one adverse event versus 14.2% of omeprazole patients (PubMed Central).

Why this matters

Gaviscon typically causes fewer systemic side effects than omeprazole, making it a preferable option for patients concerned about the broader impacts of long-term PPI use. PPIs like omeprazole may cause headaches, stomach pain, and issues with nutrient absorption over extended periods, according to EverydayMeds analysis.

The trade-off: PPIs like omeprazole may provide superior healing for erosive oesophagitis and better long-term symptom control for GERD, but Gaviscon wins on immediacy and localized action with fewer systemic effects.

What is the downside of taking Gaviscon?

The most commonly reported side effects of Gaviscon are constipation and gas, though these occur in a small percentage of users. More significantly, the tablets contain aspartame (5.6 mg per tablet), which poses a risk for people with phenylketonuria (PKU) because aspartame is a source of phenylalanine. A 4-tablet dose delivers 9.72 mmol of sodium, which is worth noting for anyone on a low-sodium diet for blood pressure management (The Independent Pharmacy).

Side effects

Allergic reactions to Gaviscon occur in fewer than 1 in 10,000 patients treated. When they do occur, symptoms may include skin rash, itching, difficulty breathing, dizziness, and swelling of the face, tongue, or throat. Other possible side effects of unknown frequency include constipation, irritability, muscle twitching, muscle cramps, and elevated blood calcium levels (The Independent Pharmacy).

Who should avoid

Gaviscon interacts with several medication classes including antihistamines, tetracycline and quinolone antibiotics, iron preparations, thyroid hormones, antifungals, digoxin, and beta-blockers. Anyone taking these medications should leave at least 2 hours between taking them and taking Gaviscon. Additionally, the calcium content means patients with hypercalcaemia or kidney stones should consult a doctor before use.

What to watch

The 9.72 mmol sodium per 4-tablet dose can add up quickly for patients managing hypertension or heart failure. Anyone watching their sodium intake should factor this into their daily totals — it is not a medication to take routinely without awareness of cumulative sodium from multiple daily doses.

The implication: for most healthy adults using Gaviscon occasionally, side effects are minimal. The population requiring the most caution comprises those on low-sodium diets, patients with PKU, and anyone taking medications that Gaviscon might interfere with.

Gaviscon Double Action vs Standard Gaviscon and Omeprazole

Three heartburn treatments, three different mechanisms: Gaviscon Dual Action combines a reflux-suppressing alginate with an acid-neutralizing antacid, standard Gaviscon relies on alginate technology alone, and omeprazole reduces acid production at the source.

Attribute Gaviscon Dual Action Standard Gaviscon Omeprazole
Primary mechanism Barrier + antacid Barrier only Acid production reduction
Onset of action 30 min to 2 hours 30 min to 2 hours 1 to 4 days for full effect
Duration per dose Several hours Several hours Up to 24 hours
Minimum age 12 years Varies by formulation Typically 18 years
Sodium per max dose 9.72 mmol Variable Negligible
Systemic effects Minimal Minimal Possible with long-term use

What this means: for patients choosing between these three options, the decision hinges on whether they prioritize immediate relief or sustained symptom management. Gaviscon Dual Action offers the fastest symptom relief for occasional heartburn because it neutralizes acid immediately while simultaneously creating a protective barrier. Omeprazole takes days to reach full effectiveness but provides sustained acid control better suited for chronic GERD. Standard Gaviscon falls between the two on the speed-versus-sustainability spectrum.

Key Specifications

The formulation details below come from pharmaceutical sources and provide the exact composition information patients need for informed decisions.

Specification Details
Active ingredients Sodium alginate, Sodium bicarbonate
Aspartame per tablet 5.6 mg
Sodium per 4-tablet dose 9.72 mmol
Calcium per 4-tablet dose 7.5 mmol
Recommended dose 2-4 tablets after meals and at bedtime
Maximum frequency 4 times daily
Administration Chew thoroughly before swallowing
Minimum age 12 years and over

The pattern: the aspartame content is the specification most likely to affect a specific subset of users. Anyone with PKU must avoid this product entirely, and anyone monitoring phenylalanine intake for other metabolic reasons should similarly steer clear.

Upsides

  • Fast-acting dual mechanism for meal-triggered symptoms
  • Localized action means fewer systemic side effects
  • Comparable efficacy to omeprazole in clinical trials for symptom relief
  • Available without prescription in most markets
  • Well-tolerated safety profile (12.6% adverse event rate)
  • Suitable for children 12 and over

Downsides

  • Contains aspartame — unsafe for PKU patients
  • Significant sodium content (9.72 mmol per 4-tablet dose)
  • Requires multiple daily doses for ongoing symptoms
  • May reduce absorption of other medications if taken simultaneously
  • Less suitable for severe erosive oesophagitis
  • Limited long-term safety data compared to PPIs

How to Take Gaviscon Double Action Tablets

Taking Gaviscon correctly maximises effectiveness and reduces the risk of side effects. The tablets must be chewed thoroughly before swallowing — they are not designed to be swallowed whole.

Standard dosage instructions

Adults and children aged 12 and over should take 2 to 4 tablets after meals and at bedtime, up to a maximum of 4 times daily when symptoms occur. If a dose is forgotten, there is no need to double the next dose — simply continue with the regular schedule (The Independent Pharmacy).

Important considerations

The tablets require thorough chewing to activate the alginate technology properly. Taking them with food or drink immediately afterward is acceptable, but taking a dose on an empty stomach may alter how quickly the protective barrier forms. For patients taking other medications, leaving a 2-hour gap between Gaviscon and other oral medicines helps avoid absorption interference.

Bottom line: Gaviscon Dual Action tablets work fast for occasional, meal-related heartburn and performed nearly identically to omeprazole in a clinical trial for achieving heartburn-free days. Patients with frequent or severe symptoms should discuss whether a proton pump inhibitor is more appropriate, and anyone on a sodium-restricted diet should factor in the 9.72 mmol per 4-tablet dose.

What the Evidence Says: Confirmed Facts and Remaining Questions

Confirmed facts

  • Gaviscon Dual Action provides dual relief through alginate barrier formation and acid neutralization (NHS)
  • In a 14-day clinical trial, 89.7% of Gaviscon patients achieved a 24-hour heartburn-free period (PubMed Central)
  • Mean time to first heartburn-free day was 2.0 days — identical to omeprazole (PubMed)
  • 12.6% of Gaviscon patients experienced adverse events versus 14.2% for omeprazole (PubMed Central)
  • Allergic reactions occur in fewer than 1 in 10,000 patients treated (The Independent Pharmacy)

Remaining questions

  • Optimal dosing frequency for patients with variable symptom patterns
  • Long-term efficacy data beyond 14 days for chronic GERD management
  • Whether the slight advantage omeprazole shows by day 7 translates to meaningful clinical differences in real-world use

The pattern in the clinical data is consistent: Gaviscon holds its own against a prescription PPI for symptom control, but the advantage shifts to PPIs when sustained daily management is required rather than episode-based relief.

“Gaviscon was non-inferior to omeprazole in achieving a 24-hour heartburn-free period in moderate episodic heartburn.”

PubMed (GOOD trial researchers)

“Gaviscon is a type of medicine called a reflux suppressant that works by suppressing stomach acid traveling up the food pipe.”

— NHS (UK health authority)

Summary

Gaviscon Dual Action tablets occupy a well-defined niche in heartburn management: fast, localized relief for occasional symptoms triggered by meals, backed by clinical evidence that puts it on par with prescription-strength alternatives for moderate episodic heartburn. The 9.72 mmol sodium per maximum dose and the presence of aspartame are practical considerations that affect specific patient groups but do not diminish the product’s value for its intended use. Patients with persistent daily heartburn or diagnosed GERD should consult a healthcare provider about whether a proton pump inhibitor is more appropriate.

Related reading: Omeprazole Side Effects vs Gaviscon · Omeprazole vs Gaviscon: Which is Right for You

Gaviscon Dual Action tablets create a protective raft against reflux, similar to strategies outlined in this Gaviscon reflux guide for everyday heartburn relief.

Frequently asked questions

What is Gaviscon Double Action tablets dosage for adults?

Adults and children 12 years and over should take 2 to 4 tablets after meals and at bedtime, up to a maximum of 4 times daily. The tablets must be chewed thoroughly before swallowing. If a dose is missed, simply continue with the regular schedule without doubling up.

How to take Gaviscon Double Action tablets?

Chew the tablets thoroughly before swallowing. Take them after meals and before bed for best results. If taking other medications, leave a 2-hour gap between Gaviscon and other oral medicines to avoid absorption interference.

What are Gaviscon Double Action Tablets ingredients?

The active ingredients are sodium alginate and sodium bicarbonate. Each tablet contains 5.6 mg aspartame. A 4-tablet dose provides 9.72 mmol sodium and 7.5 mmol calcium. The presence of aspartame makes this product unsuitable for people with phenylketonuria.

Gaviscon Double Action tablets how many to take?

Take 2 to 4 tablets per dose, after meals and at bedtime, up to 4 times daily. The exact number within this range depends on symptom severity. Do not exceed 4 doses in 24 hours.

Which Gaviscon Product Is Right for Your Heartburn?

Choose Gaviscon Dual Action if you need fast relief from occasional, meal-triggered symptoms. Choose standard Gaviscon if you prefer barrier-only protection without the antacid component. Choose a PPI like omeprazole if you have diagnosed GERD requiring daily acid management — though this requires a prescription and medical supervision.

What is the safest acid reflux medication for long term use?

Proton pump inhibitors like omeprazole are generally considered appropriate for long-term use under medical supervision, particularly for diagnosed erosive oesophagitis. However, they carry concerns about long-term nutrient absorption and systemic effects. Gaviscon is considered safe for ongoing use with fewer systemic effects, but its sodium content makes it less ideal for patients on restricted diets. Consultation with a healthcare provider is essential for any long-term acid reflux management plan.